Interventional Cardiology Devices Market Size, Share 2022-27

The latest research study “Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global interventional cardiology devices market size reached a value of US$ 19.58 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 32.21 Billion by 2027, exhibiting a CAGR of 8.40% during 2022-2027.

What is interventional cardiology devices?

Interventional cardiology devices are medical tools and equipment used to perform various cardiovascular procedures, such as angioplasty and stenting. Some commonly used devices include mitral, pulmonary, and tricuspid valves, catheters, plaque modification, angioplasty balloons, stents, and hemodynamic flow alteration devices. They are widely used in other treatments, such as percutaneous valve repair, embolic protection, and atherectomy. Currently, interventional cardiology devices find extensive applications in medical procedures, including arrhythmia treatment, aneurysm repair, coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), open-heart, off-pump heart, and minimally invasive (MI) heart surgeries.

Request a Free PDF Sample for more detailed market insights:

Interventional Cardiology Devices Market Trends and Drivers:

The global interventional cardiology devices market is primarily driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular disorders. Moreover, the increasing geriatric population, which is more prone to such ailments, is positively influencing market growth.

Additionally, the introduction of innovative pacemakers, drug-coated mesh tubes, and biodegradable and drug-eluting stents represent another major growth-inducing factor. Along with this, the increasing use of advanced imaging techniques, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR), and optical coherence tomography (OCT), to facilitate early diagnosis and timely treatment of cardiovascular diseases is contributing to the market growth.

Other factors, including extensive improvements in the medical infrastructure, inflating consumer disposable incomes, and rapid growth in the healthcare industry, are also anticipated to drive the market further.

Global Interventional Cardiology Devices Market 2022-2027 Analysis and Segmentation: 

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Who are the key players in interventional cardiology devices market?

Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.

The report has segmented the market on the basis of region, product and end user.

Breakup by Product:

  • Stents
    • Drug Eluting Stents
    • Bare Metal Stents
    • Bio-Absorbable Stents
  • Interventional Catheters
    • IVUS Catheters
    • Guiding Catheters
    • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons
    • Cutting Balloons
    • Scoring Balloons
    • Drug Eluting Balloons
    • Normal Balloons

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Read Other Report:

Pharmaceutical Robots Market Size, Trends, Growth 2022-2027

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Related Posts

One thought on “Interventional Cardiology Devices Market Size, Share 2022-27

Comments are closed.